GRI BIO INC (GRI) Stock Income Statement
NASDAQ:GRI • US3622AW5029
2.9 USD
+0.15 (+5.45%)
Last: Mar 11, 2026, 03:00 PM
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | |||
| Operating Expenses | 8.24M | 11.39M | 6.93M | 9.26M | 4.89M | |||
| Research and Development | N/A | 3.23M | 1.17M | 5.19M | 3.71M | |||
| Selling, General, and Administrative Expenses | 4.47M | 8.15M | 5.76M | 4.07M | 1.18M | |||
| Operating Income | -8.24M | -11.39M | -6.93M | -9.26M | -4.79M | |||
| Interest Income/Expense | N/A | -1.90M | 410.00K | -105.00K | -34.00K | |||
| Other Income/Expense | 0.00 | 250.00K | -506.00K | 61.00K | N/A | |||
| Non Recurring Items | N/A | 0.00 | N/A | N/A | N/A | |||
| Income Before Taxes | -8.21M | -13.04M | -7.02M | -9.30M | -4.82M | |||
| Net Income | -10.00M | -13.04M | -7.02M | -9.30M | -4.82M | |||
| EBITDA | -8.24M | -11.38M | -6.72M | -9.17M | -4.71M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.53K | -186.24K | -702.40K | -930.30K | -482.20K | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -4822.00% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -4788.00% | |||
All data in USD